From my understanding, NSF has changed their perspectives/focus over the past decade. NSF used to be focused on driving fundamental understanding/science, but now it seems now they have shifted that perspective – one of which is venturing into Biomedical Technologies.
A few questions:
1. How do we write a proposal to differentiate from the NIH SBIR proposals? Would adding small clinical studies be okay to solve an engineering problem, or should we keep that off the proposal?
2. What sorts of specific aims would the NSF like to see?
– One specific aim focuses on standard engineering efforts which just requires cash. Straightforward and clear path to complete – but absolutely essential.
– Other specific aims are developing something new and novel.